Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in Subjects With Advanced Solid Tumor. [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of GH2616 in adults with advanced solid tumors; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• GH2616

Snippet

Sponsor: Suzhou Genhouse Bio Co., Ltd. | Conditions: Advanced Solid Tumor Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING